Pharmacokinetics of active ingredients liberated according to apparently zero-order kinetics from peroral preparations
Békefi, E.; Bozzay, J.; Dávid, A.; Rusznák, I.
Acta Pharmaceutica Hungarica 52(5): 200-216
1982
ISSN/ISBN: 0001-6659 PMID: 7148475 Document Number: 188261
Document emailed within 1 workday
Related Documents
Cini, M.; Rampinelli, P. 1999: DHEA-based preparations in Italy, Europe and USA: the regulations, the active ingredients, the formulations Journal of Endocrinological Investigation 22(10 Suppl): 35-36Lippold, B.C.; Förster, H. 1984: In vivo testing of a peroral theophylline depot preparation with zero-order release Arzneimittel-Forschung 34(7): 824-829
Marciniak, D.M.; Dryś, A.; Pluta, J.; Kubis, A.A. 2008: The use of kinetic N-order model in description of active substance release from various drug forms. Part 1. Premises and mathematical analysis of the N-order model Acta Poloniae Pharmaceutica 65(1): 101-105
Zak, A.F. 1977: Bioavailability of peroral antibiotic preparations Antibiotiki 22(3): 265-279
Babálová, M.; Blahová, J.; Hupková, M.; Krcméry, V. 1994: Peroral preparations of cephalosporin antibiotics Casopis Lekaru Ceskych 133(1): 22-24
Semenov, A.I. 1975: Kinetics of the metabolism of Cm244 in chronic peroral administration Gigiena i Sanitariia 8: 111-113
Yu, V.C.; de Lamirande, E.; Horning, M.G.; Pang, K.S. 1982: Dose-dependent kinetics of quinidine in the perfused rat liver preparation. Kinetics of formation of active metabolites Drug Metabolism and Disposition: the Biological Fate of Chemicals 10(6): 568-572
Karlina, M.V.; Pozharitskaia, O.N.; Kosman, V.M.; Shikov, A.N.; Lazukina, M.A.; D'iachuk, G.I. 2010: Pharmacokinetics of hopantenic acid upon peroral administration Eksperimental'naia i Klinicheskaia Farmakologiia 73(8): 46-48
Selmeczi, B.; Kedvessy, G.; Nagy, G.; Pintyéné Hódi, K.; Tencova, A.; Kiszeleva, G. 1981: Influence of the technological procedure and additives on the dissolution rate and absorption of active ingredients. I. Physical properties of acetylsalicylic acid tablets and of the dissolution rate of the active ingredient Acta Pharmaceutica Hungarica 51(5): 222-227
Stampf 1978: In vitro studies on the interactions between active ingredients and adjuvants Die Pharmazie 33(7): 447-450
Chen, J.; Yang, C.-j.; Guo, Y.-h. 2007: Studies on accumulation of active ingredients, N, P and K in Anemarrhena asphodeloides Zhongguo Zhong Yao Za Zhi 32(15): 1504-1507
Ritschel, W.A.; Neub, M.; Denson, D.D. 1987: Meperidine pharmacokinetics following intravenous, peroral and buccal administration in beagle dogs Methods and Findings in Experimental and Clinical Pharmacology 9(12): 811-815
Geiger, C.M.; Sorenson, B.; Whaley, P. 2015: Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF International Journal of Pharmaceutical Compounding 19(5): 420-427
Wang, M.Z.; Li, B.L. 1983: High performance liquid chromatographic analysis of active ingredients of Schizandra Yao Xue Xue Bao 18(3): 209-214
Wang, Q.; Zhang, N.-N.; Li, H.-Y.; Jiang, M.; Gao, J.; Bai, G. 2012: Active ingredients in rhubarb with anti-proliferative effects on scar fibroblasts Yao Xue Xue Bao 47(12): 1618-1622
Trischler, F.; Körmendy, G. 1979: Selective determination of the content of active ingredients in Lycurim by quaternary reaction Acta Pharmaceutica Hungarica 49(1): 9-12
Puranik, S.B.; Pawar, V.R.; Lalitha, N.; Pai, P.N.S.; Rao, G.K. 2009: Residual solvent analysis in hydrochloride salts of active pharmaceutical ingredients Pakistan Journal of Pharmaceutical Sciences 22(4): 410-414
Larsson, O.; Kindmark, H.; Bränström, R.; Berggren, P.O. 1997: Mechanisms of action of peroral antidiabetics. Sulfonylurea preparations block the ATP-dependent potassium channels Lakartidningen 94(48): 4473-4477
Shen, L.; Hu, R.; Lin, X.; Hong, Y.; Feng, Y.; Xu, D.; Ruan, K. 2012: Pharmacokinetics effect of shaoyao gancao compound with different decocting methods on characteristic ingredients in rat plasma after oral administration Zhongguo Zhong Yao Za Zhi 37(1): 52-56
Fortunak, J.M.; de Souza, R.O.M.A.; Kulkarni, A.A.; King, C.L.; Ellison, T.; Miranda, L.S.M. 2014: Active pharmaceutical ingredients for antiretroviral treatment in low- and middle-income countries: a survey Antiviral Therapy 19(Suppl 3): 15-29